nteractions between RBPs and RNA regulate transcription, and transcript trafficking, decay and translation [1] [2][3] [4] [5] [6][7] , thereby modulating cell homeostasis and cell fate. Several approaches are available to characterize RNA-RBP interactions. Protein-bound RNAs (PBRs) can be purified by immunoprecipitating a specific protein and sequencing its RNA cargo 8, 9 . In addition, the cellular repertoire of polyadenylated RNA-binding proteins can be recovered by ultraviolet (UV) cross-linking RNA-RBP complexes, capturing RNA with oligo(dT), and subsequently identifying bound proteins [10] [11] [12] . However, current methods to study PBRs are challenging to scale up for a system-wide analysis of RBPs and PBRs, while oligo(dT)-based purification requires much starting material, complicating its application in dynamic conditions 13 . Furthermore, the requirement for poly(A) tails means that oligo(dT)-based methods cannot be used for bacterial systems or eukaryotic nonpolyadenylated RNAs. Published methods based on incorporation of modified nucleotides have tried to address these limitations, but they can introduce biases due to transcription-dependent nucleoside incorporation [14] [15] [16] . We have developed a method based on acidic guanidiniumthiocyanate-phenol-chloroform (AGPC) phase partition, which we name orthogonal organic phase separation (OOPS). AGPC purification enables unbiased recovery of RNA species 17,18 by generating two distinct phases: RNA migrates to the upper aqueous phase and proteins occupy the lower organic phase. UV cross-linking at 254 nm generates RNA-protein adducts that combine the physicochemical properties of the two molecules and migrate to the aqueous-organic interface 19 . We hypothesized that isolation of the interface would enable specific recovery of RBPs or PBRs by digesting the reciprocal component of the adduct.
. However, current methods to study PBRs are challenging to scale up for a system-wide analysis of RBPs and PBRs, while oligo(dT)-based purification requires much starting material, complicating its application in dynamic conditions 13 . Furthermore, the requirement for poly(A) tails means that oligo(dT)-based methods cannot be used for bacterial systems or eukaryotic nonpolyadenylated RNAs. Published methods based on incorporation of modified nucleotides have tried to address these limitations, but they can introduce biases due to transcription-dependent nucleoside incorporation [14] [15] [16] . We have developed a method based on acidic guanidiniumthiocyanate-phenol-chloroform (AGPC) phase partition, which we name orthogonal organic phase separation (OOPS). AGPC purification enables unbiased recovery of RNA species 17, 18 by generating two distinct phases: RNA migrates to the upper aqueous phase and proteins occupy the lower organic phase. UV cross-linking at 254 nm generates RNA-protein adducts that combine the physicochemical properties of the two molecules and migrate to the aqueous-organic interface 19 . We hypothesized that isolation of the interface would enable specific recovery of RBPs or PBRs by digesting the reciprocal component of the adduct.
Here we report validation and application of OOPS. Separation of free RNA from PBR provides a way to quantify the proportion of RNA cross-linked to protein, enabling precise UV dosage optimization. We show that OOPS recovers all cross-linked (CL) RNA, including long noncoding RNA (lncRNA), and all CL RBPs. Using the cytostatic agent nocodazole, we identify RNA-binding changes in metabolic enzymes and splicing regulators between arrested and released cells. Finally, we characterize the first bacterium RNA interactome (to our knowledge), confirming that OOPS can retrieve RNA-RBPs in any organism.
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containing free small RNAs ( Supplementary Fig. 1b) , suggesting that small RNAs may be less frequently cross-linked with proteins.
We compared the relative abundance of RNAs in CL and NC samples using RNA sequencing (RNA-seq). We depleted the samples of ribosomal RNA then carried out total RNA-seq on samples exposed to varying UV dosages (150-400 mJ/cm 2 ; Supplementary  Fig. 1c ). The abundance of RNA species in CL and NC RNA samples was similar, with protein-coding mRNAs predominating ( Fig. 1c and Supplementary Fig. 1d ). Crucially, the Pearson correlation between CL and NC samples was as high as that in CL samples (median correlations 0.89 and 0.92, respectively; Fig. 1d and Supplementary Fig. 1e ), and, as RNA size does not affect abundance at the interface after CL, these data suggest that all CL RNAs over 60 bp are recovered without any systematic bias ( Supplementary Fig. 1f ).
Despite the high correlation between RNA abundance in CL and NC samples, we observed an overall reduction of coverage in the 3′ untranslated regions (UTRs) of mRNAs ( Fig. 1e ) and a loss of coverage at discrete positions (Fig. 1f) . We hypothesized that this was due to steric hindrance of reverse transcription at sites of RNA-protein cross-linking, as protein-RNA binding occurs frequently within the 3′ UTR 20 . We therefore applied a sliding window approach to identify 'loss of coverage' sites in the CL samples transcriptome (Supplementary Note). Loss of coverage occurred more frequently in mRNA 3′ UTRs, and sites significantly overlapped with ENCODE eCLIP protein-binding peaks 21 , confirming that they represent protein binding ( Fig. 1g and Supplementary Fig. 1g ). An alternative explanation is that adjacent uracils can photo-dimerize upon exposure to 254-nm UV, generating adducts that block reverse transcription 22 . Regions of RNA with high uracil content, which preferentially cross-link to proteins at 254 nm, were more likely to contain a detectable loss of coverage, but adjacent uracils had no effect ( Supplementary  Fig. 1h ). Protein-RNA cross-linking is the most likely cause of ) and NC replicates. Red shading denotes regions with consistently reduced coverage in CL. g, Relationship between the number of eCLIP proteins with a peak in a sliding window and the probability of the window being identified as a protein binding site. For random shuffle, the center value is the mean and error bar is 2 s.d., n = 100 iterations. h, Read coverage across RMRP for CL (400 mJ/cm 2 ) and NC replicates. Red boxes denote regions with consistently reduced coverage in CL. Non-cross-linked, NC; cross-linked, CL.
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NAtURE BiOtECHNOlOgy observed differences in read coverage, and OOPS can therefore identify protein-binding footprints.
Identification of discrete protein-binding sites was restricted to coding genes since these are more highly expressed. We also manually inspected highly expressed lncRNAs and observed a loss of coverage at small nucleolar RNA host gene 16 (SNHG16) and RNA component of mitochondrial RNA processing EndoRNase (RMRP; Fig. 1h and Supplementary Fig. 1i ). RMRP has two functions: initiating mitochondrial DNA replication and RNA processing. The 5′ site we identify matches the previously identified binding sites for the multifunction RBP HuR 23 , which promotes RMRP migration from the cytoplasm to the mitochondria 24 . However, confirmation that this loss of coverage is directly due to HuR binding will require an independent approach.
Recovery of RNA-binding proteins. Next we identified proteins cross-linked to RNA. Notably, this required less than 1% of the cells needed in previous RBP-capture methods 10, 25 (Methods). First, we used stable isotope labeling by amino acids in cell culture (SILAC) 26 to determine the relative abundance of proteins from CL and NC U2OS cells in the same OOPS interface ( Fig. 2a and Methods). Repeated phase separation removed non-cross-linked proteins, with three repeat separations optimal (Fig. 2b , Supplementary  Fig. 2a and Supplementary Table 1) . As glycosylated proteins share the physicochemical properties of RNA-protein adducts, their presence at the interface was CL independent. In contrast, nonglycosylated proteins showed a similar CL enrichment, whether or not they were Gene Ontology (GO)-annotated as RBPs (Fig. 2b) . These data confirm that cross-linking enriches RBPs in the interface.
Excluding glycoproteins, 73% of proteins were enriched at the third interface after UV-cross-linking ( Supplementary Fig. 2b,d,e) . A similar proportion of proteins was enriched with a lower UV dosage (150 mJ/cm 2 ; Supplementary Fig. 2e ). CL-enriched proteins showed a clear over-representation of RNA-related GO terms (Fig. 2c) . Within the CL-independent proteins, after accounting for protein abundance, there was a clear over-representation of RNAbinding GO terms (Fig. 2d) , suggesting that CL enrichment alone is not sufficient to distinguish free proteins from RNA-bound proteins.
To establish that the presence of the proteins at the interface was RNA-dependent, we treated the interfaces with RNases and measured protein migration to the organic phase (Fig. 2e, Supplementary  Fig. 2f ,g and Methods). Proteins that migrated to the organic phase included those that were CL independent, suggesting their presence in the interface is RNA dependent, but their interaction with RNA was stable even in the absence of CL ( Fig. 2f and Supplementary  Fig. 2h ). Moreover, proteins not annotated as RBPs showed similar RNase sensitivity to those annotated as RBPs, suggesting they may be undiscovered RBPs (Fig. 2g) . In contrast, glycoprotein abundance at the interface was unaffected by RNase ( Supplementary  Fig. 2i ). Since the presence of glycoproteins at the interface was also CL independent (Fig. 2i) , we excluded them from downstream analyses. Ninety-three percent of proteins in the organic phase were RNase sensitive, whereas those absent were largely RNase insensitive (Fig. 2h) . Ninety-six percent of proteins extracted from the organic phase showed an enrichment following RNase treatment (Fig. 2i) and a clear over-representation of GO terms related to RNA binding ( Supplementary Fig. 2j ). Moreover, canonical RBPs were in the organic phase after RNase treatment ( Supplementary  Figs. 2f and 7a) . Together, these experiments in U2OS cells show that RNase treatment is necessary. Similar results were obtained in HEK293 cells (Supplementary Fig. 2c-e,g-i) .
OOPS identifies canonical and novel RBPs. RBPs identified using OOPS were compared with those from oligo(dT) RBP-capture analysis. Eighty-three percent of proteins identified by RBPcapture in U2OS cells were also identified by OOPS (Fig. 3a and Supplementary Fig. 3a ). For proteins identified using only one method, there was significant over-representation of GO-annotated RBPs (P < 2.2 × 10 -16 , Fisher's exact test). We applied OOPS to MCF10A (a cell line derived from a healthy individual) and HEK293, and observed a RBPome in common of 759 proteins in all three cell lines (Fig. 3b, Supplementary Fig. 3b and Supplementary  Table 2 ). Interestingly, the 264 proteins that were specific to the tumor-derived cell lines had an over-representation of cell cycle RBPs ( Supplementary Fig. 3c ), indicating previous RBP cataloging experiments in these cell lines may have identified RBPs with limited RNA binding in nontumor cells. A comparison of the 1,838 proteins from the three cell lines used in this study with all previous human RBP-capture data showed 71% identity (Fig. 3c) . In addition, OOPS identified 80% of the proteins isolated by poly(A)-independent RICK 15 and CARIC 14 methods ( Supplementary Fig. 3d ,e). These results indicate that OOPS recovers most of the annotated RBPome, including proteins that do not bind polyadenylated RNAs.
As expected, OOPS RBPs showed an over-representation of GO terms describing all forms of RNA binding, including 5′ and 3′ UTR sites and single-and double-stranded RNA binding ( Fig. 3d and Supplementary Fig. 3f,g ). Previously unknown RBPs identified by OOPS showed an over-representation of GO terms related to mRNA transport and RNA localization ( Fig. 3e and Supplementary  Fig. 3h ). We projected OOPS RBPs onto our published hyperLOPIT data 27 , which identifies the average localization of proteins, as an initial indication of the subcellular distribution of the RNA-bound fraction. Known RBPs mainly localized to the nucleus, mitochondria, cytosol and large protein complexes (for example, ribosomes; Fig. 3f ), whereas previously undetected RBPs were more broadly distributed, with a greater proportion of membrane proteins and proteins of indeterminate localization (Fig. 3f) . Since membrane proteins are generally under-represented in mass spectrometry experiments, we performed a crude cell fractionation to separate cellular compartments into three fractions: 'heavy membranes' (for example, nucleus, mitochondria), 'light membranes' (for example, endoplasmic reticulum, plasma membrane) and 'cytosol' (Supplementary Figs. 3i and 7b) and confirmed that transmembrane domain-containing RBPs were more abundant in membrane fractions ( Supplementary Fig. 3j ). RBPs were detected from all fractions, with the membrane fractions yielding more previously unknown membrane RBPs and RBPs that are known to function in RNA trafficking ( Fig. 3f and Supplementary Table 3) . Most of the trafficking RBPs are related to the nuclear pore complex and the transport between nucleus and cytoplasm, but we also identified unconventional myosin-1C (MYO1C), which is involved in the movement of GLUT4-containing vesicles to the plasma membrane 28, 29 and associates with the RNA polymerase II in the nucleus 30 . Our hyperLO-PIT data indicate the steady-state localization of MYO1C is in the secretory pathway, suggesting its RNA binding may have a role in RNA trafficking. Combining OOPS with fractionation thus recovers RBPs from previously under-represented compartments.
High-throughput validation of RBPs. To validate the identified RBPs and map their RNA-binding sites, we developed a method to identify RNA-binding sites based on RNA-binding domains (RBD) map 25 ( Fig. 4a and Methods). The RNA-peptide enrichment techniques used were orthogonal to OOPS to provide independent validation of RNA binding capacity. Detected trypsin peptides can be mapped to the Lys-C RNA-peptide to determine the RNA binding region. Where possible, this region is further refined on the basis of the presence or absence of expected trypsin peptides across the Lys-C peptides, since trypsin RNA-peptides will not be identified owing to the variable mass shift of the RNA-peptide adduct ( Supplementary Fig. 4a,b Supplementary Fig. 4a ). Despite this, we identified discrete putative RNA-binding sites in 544 (40%) of OOPS U2OS proteins using the adjacent peptides. This validation rate compares favorably with the 30% of RBP-capture proteins in which an RNA binding site could be identified via sequential digestion using RBDmap 25 . As expected, putative binding sites were more easily identified in proteins with a higher abundance at the interface, with a binding site identified for 59% of the most abundant novel RBPs ( Fig. 4b and Supplementary Table 4) .
To confirm the specificity of our approach, we focused on proteins containing annotated RNA-recognition motifs (RRMs), and observed a substantial overlap between identified sites and RRMs (Fig. 4c) . To further test these sites, we inspected published structures of RBP-RNA complexes. For example, the crystal structure of the glycyl-tRNA synthetase in complex with tRNA-Gly 31 confirms that the detected binding site is less than 4 Å from the tRNA (Fig. 4d) . We further observed protein-RNA contacts in 17 proteins of the ribosome quality control complex structure previously detected using RBP-capture, together with a novel RBP detected by OOPS 32 ( Supplementary Fig. 4c ). Finally, we established that our method identifies known RNA-binding domains in GO-annotated RBPs, including the canonical RRM and KH domains, as well as noncanonical helicase C-terminal 33, 34 RBPs. c, Top ten molecular function GO terms over-represented in proteins enriched by CL in the third interface. BH adj P: Benjamini-Hochberg adjusted P-value. P-value obtained from a modified hypergeometric test to account for protein abundance (see Methods). d, As per c for proteins not enriched by CL in the third interface. e, Schematic representation of the SILAC experiment to determine protein abundance in the third interface and fourth organic phase following RNase treatment. Equal quantities of cells were UV cross-linked and RNA-protein adducts were enriched by OOPS with or without RNase before combining the samples for a final phase separation in which both the interface and the organic phase were collected. Proteins from RNasetreated cells will be depleted from the interface (Int) and enriched in the organic phase (Org). f, Protein CL/NC ratio and RNase/control ratio in the interface. Red box denotes proteins that are not CL-enriched and not depleted by RNase. Blue regions outside the graph denote ratios that cannot be accurately estimated as the protein was only detected in one condition and therefore a pseudo-value is presented. g, RNase/control ratio in the interface for GO-annotated RBPs and other OOPS RBPs. h, Protein RNase/control ratio in the interfaces for proteins identified in the fourth step organic phase. Red line, equal intensity in RNase-treated and control. i, Proportion of proteins enriched in the organic phase following RNase treatment. Significant (sig.) enrichment was detected using a two-tailed Mann-Whitney-Wilcoxon test (Benjamini-Hochberg adjusted P < 0.05). Proteins detected in only RNase or control were deemed enriched or depleted, respectively. Proteins detected in both RNase and control but with insufficient peptides (fewer than six) to test for enrichment are excluded.
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NAD-binding pocket of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 35 , which confirmed previous RNA-binding site predictions based on in vitro experiments 36 ( Fig. 4f) . Notably, proteins with assigned RNA binding sites include some pharmacological targets. We found 21 proteins with known inhibitors in the IUPHAR/ BPS Guide to Pharmacology 37 , 5 of which are targets of approved Supplementary Fig. 4e ). This surprising observation of shared interaction sites for RNA and drugs indicates that future studies would benefit from considering the RNA-binding role of these proteins.
Assessment of RNA binding in a dynamic system. Next we applied OOPS to a dynamic system using a microtubule depolymerizing agent. Microtubule depolymerizing drugs arrest cells in prometaphase by inhibiting chromosome alignment and segregation, and they affect a wide range of other cellular processes, such as intracellular transport and mitochondrial replication [38] [39] [40] [41] [42] [43] . U2OS cells were arrested with nocodazole and dynamic changes in RNA binding were determined following a short (6 h) and long (23 h) recovery using tandem mass tag (TMT) quantification (Fig. 5a,b, Supplementary Fig. 5a and Methods). These experiments required only 0.07 m 2 of cell culture, compared to the 19-27 m 2 that would be required using RBP-capture 10, 11 . As expected, we observed increased abundance of spindle proteins at 0 h relative to 6 h, demonstrating that nocodazole arrested cells at the spindle checkpoint ( Supplementary Fig. 5b ). Quantifying protein abundance in OOPS and total cell lysates of the same sample (Fig. 5b) revealed changes in RNA binding independent of concurrent changes in total protein abundance. Notably, changes in OOPS-enriched protein abundance frequently did not correlate with variations in total protein abundance, suggesting that specific RBPs bind RNA differentially in different cell cycle stages ( Fig. 5c and Supplementary Table 5) .
To better understand protein dynamics, we used a linear model framework to identify proteins with changes in RNA binding, taking into account their total abundance (see Methods). We focused on changes occurring between cell in arrest and 6 h after release. KEGG pathway 44 and GO term over-representation analysis identified pathways with altered RNA binding between arrest and release ( Supplementary Figs. 5c and 6e ). Open mitosis is associated with a global inhibition of RNA processing, including splicing and translation 45, 46 . In agreement, 20 of 23 tRNA synthetases detected showed lower RNA binding during nocodazole prometaphase arrest, suggesting a coordinated decrease in aminoacyl-tRNA availability ( Supplementary Fig. 5d ). Conversely, we saw increased RNA binding in nocodazole arrest for components of the spliceosome ( Supplementary Fig. 5e,f) , including SRS10, which can inhibit splicing in mitosis 47 . Nocodazole affects mitochondrial activity and cellular metabolism 42, 43, 48 . We indeed observed an over-representation of proteins involved in metabolic processes including pyruvate, fatty acid and amino acid metabolism, and glycolysis in the proteins with 
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increased RNA binding after release, which was maintained at 23 h ( Fig. 5d and Supplementary Figs. 5c and 6e ). To further explore the effect of nocodazole arrest and release on metabolic enzyme RNA binding, we carried out another experiment using a complementary approach, thymidine-nocodazole arrest ( Supplementary Fig. 6 ). Comparing arrested cells with an untreated population, we found a similar RNA binding profile for mitochondrial and metabolic proteins. The increase in the RNA binding capacity of these proteins after release points to a gain of RBP activity after the disruptive effects of nocodazole on microtubule formation dissipate.
Many metabolic proteins have been described as eukaryotic RNA-binding proteins 12, 49, 50 . However, this is the first demonstration, to our knowledge, of dynamic RNA-binding for these RBPs.
OOPS characterization of the E. coli RBPome. OOPS is not limited to polyadenylated RNA, so we used it to obtain the RBPome of E. coli (Methods). We detected 364 proteins (Fig. 6a ) in all five replicates, which represents ~8% of the predicted K-12 strain proteome 51 , and is similar to the proportion obtained in eukaryotic cells. We recovered 87 of 176 GO-annotated RBPs (Fig. 6b and Supplementary Table 2 ) and observed that the over-represented GO terms for OOPS RBPs were related to RNA binding, including "rRNA binding, " "tRNA binding" and the more general "nucleic acid binding" (Fig. 6c) . Furthermore, of the 277 novel OOPS RBPs reported here, we find a clear enrichment for RNA-associated GO terms, mainly relating to tRNAs or noncoding RNAs (Fig. 6d) . However, 234 of 364 OOPS RBPs are not annotated with an RNA-related GO term, suggesting OOPS can reveal new RBP functions in prokaryotes.
Recent observations suggest that, in E. coli, transcription and translation are not always linked and RNA can be sequestered in helix-like structures, or be localized to the poles or the middle of the cell, or distributed near the plasma membrane 52, 53 . P5CR2  SUCB2  AATC  CNDP2  ECHB  P5CR1  ALDH2  AL3A2  SCOT1  THIL  THIM  MUTA  AATM  ACADV  AL1B1  AMPL  DLDH  AL9A1  P5CS  HIBCH  MMSA  ACSL4  ECHM  ADHX  ECHA  HMCS1  LDHA  LDHB   SUCB1  SDHB  PCKGM  PGM2  ACACA  LGUL  MDHC  FUMH  IDHC  ENOB  ODP2  SUCB2  ODPA  SDHA  PGM1  MAOM  IDH3A  ACOC  AK1A1  ALDH2  AL3A2  ODPB  THIL  ENOG  HXK2  AL1B1  ACLY  ODO2  DLDH  AL9A1  CISY  ADHX  HXK1  PGAM1  PGK1  TPIS  LDHA  LDHB  ENOA  KPYM  G3P Total 
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Interestingly, we found RBPs that follow these RNA localization patterns (Fig. 6e) , suggesting their potential implication in bacterial subcellular RNA organization. Many of the glycolytic enzymes that bind RNA in Homo sapiens also bind RNA in E. coli (Fig. 6f) . Enolase 1 and pyruvate kinase, detected in previous RBP-capture studies, were identified as RBPs by OOPS in E. coli. Furthermore, GAPDH and phosphoglycerate kinase, previously described as low-confidence candidate RBPs in human by RBP-capture, and phosphoglycerate mutase, a glycolytic protein not previously identified in any human RBP-capture, were also found as RBPs in our human and bacterial studies.
Discussion
OOPS retrieves both cross-linked RNAs representing the complete cellular transcriptome and their cross-linked RBPs. Our results agree with independent data from previous RBP identification methods. Importantly, OOPS detects new RBPs from under-represented subcellular compartments, identifies specific RNA-protein interactions, characterizes dynamic systems and can interrogate bacteria.
Although OOPS recovers RNAs in an unbiased manner from both the aqueous phase and the interface after UV cross-linking, we observe an under-representation of small RNAs (sRNAs) in the PBR fraction. One explanation is that tRNAs, one of the most abundant sRNA species, are less frequently protein bound, as has been observed in bacteria 54 . Overall, sRNAs have a lower probability of UV crosslinking to proteins, as their shorter length results in fewer simultaneous interactions. Despite this, we consistently found sRNA-binding proteins in both human and bacteria, including canonical (Hfq) and recently discovered (ProQ) E. coli sRNA binding proteins 55 . Although we primarily performed RNA-seq to demonstrate that OOPS recovers all CL RNAs, we were further able to identify putative protein binding sites, including some within lncRNAs. With increased read coverage at lncRNAs by depletion of mRNAs, enrichment of lncRNAs 56 , and/ or increased overall sequencing depth, it would be possible to provide a broad assessment of protein binding on lncRNAs, which would help prioritize functional studies of lncRNAs.
OOPS exploits the separation of macromolecules by their physicochemical properties. As such, glycoproteins and RNA-protein adducts cannot be distinguished since glycans and RNAs are both hydrophilic polymers. Our observation that the interface abundance of most glycoproteins is cross-linking independent and RNase insensitive suggests that they do not bind RNA. Despite this, we note that 17 of 21 glycoproteins enriched by cross-linking are localized to the exosome (a RNA-rich compartment [57] [58] [59] ), and these 
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NAtURE BiOtECHNOlOgy include 4 known RNA-binding glycoproteins 10, 60 . To completely catalog RNA-binding glycoproteins, it would be necessary to remove glycans. Achieving this in a manner that does not degrade RNA is nontrivial. We therefore took a conservative approach and discounted glycoproteins from our analyses.
Cross-linking-based detection of RBPs is based on proximity of RNAs and proteins. Currently, proteins cross-linking to RNA are referred to as RBPs, since UV cross-linking occurs at zero distance, implying binding. However, highly abundant proteins are more likely to contact RNAs at random. Therefore, characterizations of the RBPome inferred by UV cross-linking-based methods need, at a minimum, to account for the abundance of proteins in the cell, as we do here. Moreover, since some proteins may interact nonfunctionally with RNA, the functional relevance of some catalogs should be considered with caution 19 . Dynamic experiments provide one method to interrogate the biological function of RNA-protein interactions and can uncover system-wide changes in RBPs.
One of the most striking findings presented here is the coordinated increase in RNA binding of metabolic enzymes following release from nocodazole arrest. Considering the previously described regulation of the thermal stability of glycolytic proteins in response to nocodazole arrest 48 and the reported repression of translation by GAPDH in response to changes in glycolytic flux 61 , our results provide further evidence for a possible link between metabolism and RNA binding. Many metabolic proteins have been described as RNA-binding proteins, although this remains a controversial proposition 12, 49, 50 . Here we confirmed by SILAC that the presence of glycolysis-and tricarboxylic acid cycle-related proteins in OOPS interfaces is cross-linking dependent and RNase sensitive ( Supplementary  Fig. 5g ), supporting their capacity to interact with RNA. In particular, GAPDH has been shown to bind to a range of RNA species including tRNAs, AU-rich elements and the telomerase RNA component (TERC) 62, 63 . In vitro experiments suggest binding occurs within its NAD-binding crevice, but this has not been observed in vivo 36, 62, 64 . Here we provide, to our knowledge, the first in vivo evidence of GAPDH RNA binding in the NAD-binding crevice.
Subcellular transcriptome organization has been proposed to contribute to protein localization in eukaryotes 65 . In bacteria, spatial transcriptome distribution has historically been underappreciated, but it now appears RNA may adopt discrete distributions 52, 53 : close to the membrane, in a helical arrangement, close to the poles, or medial. Moreover, RNA distribution may relate to the localization of the protein product. For example, RNA proximity to the plasma membrane has been found to be more prevalent in the transcripts that encode membrane proteins, as a result of their localized translation at the membrane 66 . Here we find that the peripheral membrane protein SecA is an RBP. Interaction between SecA, an ATPase component of the bacterial protein translocase system, and the ribosome is thought to be mediated by a protein-protein interaction with the ribosomal L23 protein 67, 68 . However, our data suggest that SecA may also directly interact with RNA, making it a candidate to localize RNA to the membrane. Moreover, we further determined that proteins known to follow helical, distal and medial distributions, such as MreB 69 , MinD 70, 71 or FtsZ
72
, can interact with RNA, making them candidates for future targeted studies of RNA localization.
OOPS is a highly efficient, low-cost method for the isolation of RNA-protein complexes in any organism, enabling the analysis of both the RNA and protein components. This simple method will make RNA-protein interaction studies more accessible. We hope this will foster a systems biology view of their function by permitting the study of their dynamic properties.
Online content
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41587-018-0001-2.
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Methods
Cell culture. U-2 OS (U2OS) and MCF 10A cells were obtained from the American Type Culture Collection (ATCC). HEK293 were kindly provided by Johanna Rees (University of Cambridge). U2OS and HEK293 cells were cultured in McCoy's 5A and DMEM (Gibco-BRL) media, respectively, supplemented with 10% FBS (Gibco-BRL). MCF 10A were maintained in MEBM medium (Lonza/ Clonetics) supplemented with 10 ng/ml of cholera toxin (Sigma-Aldrich). All cells were maintained at 37 °C and 5% CO 2 and regularly tested for mycoplasma contamination with negative results.
E. coli K-12 DH5a strain (Thermo Fisher Scientific) was cultured in LB broth (Thermo Fisher Scientific) at 37 °C. All E. coli experiments were done at stationary phase after 16 h of cell growth.
OOPS in human cells. Cells were cultured in 6-cm-diameter dishes (28.2 cm 2 ) for catalog experiments, or 10-cm-diameter dishes (78.5 cm 2 ) for dynamic experiments, until a maximum of 90% of confluence was reached, using a single dish per replica and condition. Cells were washed twice with PBS and supernatant removed by pipetting. In non-cross-linked controls, cells were immediately lysed by scraping in acidic guanidinium-thiocyanate-phenol (Trizol, Thermo Fisher Scientific), and the homogenate was transferred to a new tube. In cross-linked samples, UV cross-linking was performed on PBS-washed cells by UV irradiation at 254 nm (CL-1000 Ultraviolet Crosslinker; UVP). Immediately after crosslinking, cells were scraped in Trizol and the homogenized lysate was transferred to a new tube and incubated at room temperature (RT) for 5 min to dissociate unstable RNA-protein interactions. For biphasic extraction, 200 µ L of chloroform (Fisher Scientific) were added, phases were vortexed, and the sample was centrifuged for 15 min at 12,000g at 4 °C. The upper, aqueous phase (containing non-cross-linked RNAs) was transferred to a new tube and RNA precipitated following manufacturer instructions. The lower, organic phase (containing noncross-linked proteins) was transferred to a new tube and proteins precipitated by addition of nine volumes of methanol (Fisher Scientific). Interface (containing the protein-RNA adducts) was subjected to extra AGPC phase separation cycles, precipitated by addition of nine volumes of methanol, and pelleted by centrifugation at 14,000g, RT for 10 min.
For RNA analyses, the precipitated interfaces were incubated for 2 h at 50 °C in 30 mM Tris HCl (pH 8), 10 mM EDTA and 18 U of proteinase K (Thermo Fisher Scientific). Samples were cooled and released RNA was purified by standard phenol/chloroform extraction (Thermo Fisher Scientific) according to the manufacturer instructions.
For RNA-binding protein analyses, the precipitated interface was resuspended in 100 µ L of 100 mM triethylammonium bicarbonate (TEAB), 1 mM MgCl 2 , 1% SDS, incubated at 95 °C for 20 min, cooled and digested with 2 µ g RNase A, T1 mix (2 mg/mL of RNase A and 5,000 U/mL of RNase T1, Thermo Fisher Scientific) for 2-3 h at 37 °C. Another 2 µ g of RNase mix was added and incubated overnight at 37 °C, after which a final cycle of AGPC phase partitioning was performed and released proteins recovered from the organic phase by methanol precipitation.
OOPS in bacteria.
E. coli cultures were grown overnight. Three milliliters of culture were pelleted by centrifugation (5 min at 6,000g, RT) and washed twice with PBS. Cells were resuspended in PBS and cross-linked in solution at 254 nm with 525 mJ/cm 2 . Cross-linked cells were pelleted again and supernatant removed by pipetting, leaving approximately 50 µ L of PBS. 500 µ L of 0.5-mm glass beads (Sigma-Aldrich) were added to each sample, mixed gently, frozen on dry ice and dried by sublimation for 2 h. Dried cells were disrupted by vortexing for 5 min, at intervals of 1 min to avoid warming the sample. One milliliter Trizol was added to each tube and samples were homogenized by vortexing. Supernatant (avoiding glass beads) was transferred to a new tube and centrifuged 5 min at 6,000g at 4 °C. The supernatant was transferred to a new tube, leaving the unlysed cells as a pellet. Finally, OOPS was performed as described above.
RNA quantification and integrity assessment. RNA purity was assessed by Nanodrop (Thermo Fisher Scientific). Samples with a 260/280 nm absorbance ratio below 1.9 or 260/230 absorbance ratio below 2 were discarded. RNA concentration was estimated using the Qubit RNA BR (Broad-Range) Assay Kit (Thermo Fisher Scientific) in a Qubit 2.0 Fluorometer (Thermo Fisher Scientific). RNA integrity was evaluated using the Agilent 2100 Bioanalyzer system (Agilent).
RNA sequencing. Protein-bound RNA (PBR) and total non-cross-linked (NC) RNA were purified using OOPS or standard Trizol extraction, respectively. All RNA samples were treated with Turbo DNase (Thermo Fisher Scientific). Ribosomal RNA (rRNA) was depleted using RiboCop kit V1.2 (Lexogen, Greenland, NH, USA) according to manufacturer instructions, starting with 1 μ g of RNA. Two nanograms of rRNA-depleted NC RNA or 8 ng of rRNA-depleted PBR were used to generate sequencing libraries using the SENSE total RNA-Seq Library Prep kit (Lexogen). All libraries were sequenced in parallel on a NextSeq 500 for 75 cycles (Illumina).
RNA-seq data processing and bioinformatics. Quality control of raw fastqs was performed using FastQC (http://www.bioinformatics.babraham.ac.uk/projects/ fastqc/). Reads were aligned to the hg38 human genome and Ensembl 87 73 using hisat2 74 with default settings, and reads with MAPQ < 10 were discarded. Transcript quantification was performed with Salmon 75 using default settings. The meta-plot of read coverage over gene model was obtained using the CGAT bam2geneprofile script with reporter = utrprofile 76 . For details of the identification of putative protein binding sites and the overlap with eCLIP data, see Supplementary Note.
Oligo(dT) RBP-capture. RBP-capture was performed according to ref. 25 , with the following modifications. We used four 500 cm 2 plates per condition. Oligo(dT) 25 magnetic beads (NE Biolabs) were reconditioned as per manufacturer's instructions and incubated with the lysates for a second round of RBP-capture. Eluates from the two rounds were pooled. Subcellular fractionation. U2OS cells from a single 80% confluent 500 cm 2 cell culture dish (Sigma-Aldrich) were detached using trypsin without EDTA (Thermo Fisher Scientific), pelleted 5 min at 250g, washed with PBS, resuspended in 50 ml of PBS and cross-linked in solution at 254 nm with 400 mJ/cm 2 . Cells were pelleted again for 5 min at 250g, resuspended in 1 ml of lysis buffer (0.25 M sucrose, 10 mM HEPES pH 7.4) containing protease inhibitors (Roche), and lysed with a ball bearing homogenizer (Isobiotec) on ice. Unlysed cells were removed by centrifugation at 200g, 5 min at 4 °C. The supernatant was transferred to a new tube and centrifuged at 1,000g, 10 min at 4 °C, with the pellet collected as 'heavy membrane fraction' . The supernatant was centrifuged again at 12,200g, with the pellet collected as the 'light membrane fraction' . The supernatant was collected as cytosolic fraction, frozen and dried by sublimation by SpeedVac (Labconco). Pellets from the heavy membranes, light membranes and cytosol were resuspended in Trizol and RBPome and total proteome were extracted using OOPS. . Cell lysates were obtained by directly scraping the cross-linked cells in AGTP. The total proteome was extracted from the lysate and the RBPome was determined using OOPS (see "OOPS in human cells").
Double thymidine-nocodazole arrest.
A single 10-cm-diameter dish (per replica and condition) of U2OS cells at 70% of confluence was arrested in G1/S phase by incubating the cells with 2.5 mM of thymidine (Sigma-Aldrich) for 18 h. After the first thymidine block, cells were washed twice with PBS and incubated for 16 h with medium containing 100 ng/ml of nocodazole (Sigma-Aldrich). To collect our 0-h time point, cells were washed twice with PBS and released from nocodazole arrest for 20 min before being cross-linked at 254 nm with 400 mJ/cm 2 . Cells were detached by mechanical stimulation, pelleted and solubilized in AGTP (Trizol) and stored at -80 °C. For the post-release time point (6 h after arrest), total cell lysate and OOPS preparation, cells were handled with the same conditions as for the single nocodazole arrest.
A parallel cell dish was cultured for every time point and replicate to assess by flow cytometry the arrest efficacy and the recovery after release. DNA content per cell was analyzed using the Propidium Iodide Flow Cytometry Kit (Abcam) as indicated by the manufacturer. Flow cytometry results were analyzed using FlowJo 8.7, manually determining the different cell populations according to their DNA content (2 N, G1; 2-4 N, S; 4 N, G2/M).
Proteomic sample preparation. Samples were resuspended in 100 µ L of 100 mM TEAB (Sigma-Aldrich), reduced with 20 mM DTT (Sigma-Aldrich) at room temperature for 60 min and alkylated with 40 mM iodoacetamide (Sigma-Aldrich) at room temperature in the dark for at least 60 min. Samples were digested overnight at 37 °C with 1 µ g of trypsin (Promega), with the exception of samples for TMT labeling, which were digested overnight at 37 °C with 1 µ g Lys-C (Promega). Subsequently, 1 µ g of modified trypsin (Promega) was added, and the samples were incubated for 3-4 h at 37 °C. Samples were then acidified with TFA (0.1% (v/v) final concentration; Sigma-Aldrich) and centrifuged at 21,000g for 10 min. The supernatant was frozen at -80 °C until required.
For peptide clean-up and quantification, 200 µ L of Poros Oligo R3 (Thermo Fisher Scientific) resin slurry (approximately 150-200 µ L resin) was packed into Pierce centrifuge columns (Thermo Fisher Scientific) and equilibrated with 0.1% TFA. Samples were loaded, washed twice with 200 µ L 0.1% TFA and eluted with 300 µ L 70% acetonitrile (ACN) (adapted from ref. 77 ). Ten microliters were taken from each elution for Qubit protein assay (Thermo Fisher Scientific) quantification, with the remaining sample retained for MS. Table 6 details the main parameters used for each sample.
LC-MS/MS. Supplementary
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isotopes (SILAC Protein Quantitation Kit, Thermo Fisher Scientific). SILAC and unlabeled samples generated from OOPS experiments in E. coli and MCF10A were acquired using charge-ordered parallel ion analysis (CHOPIN) acquisition in positive ion mode as previously reported 78 , using an Orbitrap Fusion Lumos (Thermo Fisher Scientific) coupled to a nanoLC Dionex Ultimate 3000 UHPLC (Thermo Fisher Scientific). Samples for direct assessment of RNA cross-linking site were acquired in the Orbitrap Fusion Lumos using HCD fragmentation and detection in the Orbitrap analyzer.
TMT-11plex or TMT-10plex (Thermo Fisher Scientific) labeling from desalted peptides was performed according to the manufacturer's protocol. Equal amounts of desalted peptides were labeled immediately after being quantified with Qubit protein assay (Thermo Fisher Scientific). Multiplexed TMT samples were separated into four fractions using a Pierce High pH Reversed-Phase Peptide Fractionation Kit (Thermo Fisher Scientific). TMT labeled fractions were analyzed in an Orbitrap Fusion Lumos. Mass spectra were acquired in positive ion mode applying data acquisition using synchronous precursor selection MS 3 (SPS-MS 3 ) acquisition mode 79 . Samples from oligo(dT) capture and from subcellular fractionation were analyzed in an Orbitrap Nano-ESI Q-Exactive mass spectrometer (Thermo Fisher Scientific), coupled to a nanoLC (Dionex Ultimate 3000 UHPLC).
All samples were analyzed in a 120-min run except for TMT-labeled fractions (240 min) and RNA cross-linking site assessment samples (60 min).
MS spectra processing and peptide and protein identification. Raw data were viewed in Xcalibur v.2.1 (Thermo Fisher Scientific), and data processing was performed using Proteome Discoverer v2.1 (Thermo Fisher Scientific). The raw files were submitted to a database search using Proteome Discoverer with Mascot, SequestHF and MS Amanda 80 algorithms against the Homo sapiens database for U2OS, HEK-293 and MCF 10 A cells or E. coli database downloaded in early 2017, containing human (or E. coli) protein sequences from UniProt/ Swiss-Prot and UniProt/TrEMBL. Common contaminant proteins (several types of human keratins, BSA and porcine trypsin) were added to the database, and all contaminant proteins identified were removed from the result lists before further analysis. The spectra identification was performed with the following parameters: MS accuracy, 10 p.p.m.; MS/MS accuracy of 0.05 Da for spectra acquired in Orbitrap analyzer and 0.5 Da for spectra acquired in Ion Trap analyzer; up to two missed cleavage sites allowed; carbamidomethylation of cysteine (as well as TMT6plex tagging of lysine and peptide N terminus for TMT labeled samples) as a fixed modification; and oxidation of methionine and deamidated asparagine and glutamine as variable modifications. Arginine (+ 10.008 Da) and lysine (+ 8.014 Da) were also set as variable modifications in SILAC-labeled samples. Percolator node was used for false discovery rate estimation and only rank 1 peptide identifications of high confidence (FDR < 1%) were accepted. A minimum of two high-confidence peptides per protein was required for identification using Proteome Discoverer, except in samples for RNA cross-linking site assessment.
TMT reporter values were assessed through Proteome Discoverer v2.1 using the Most Confident Centroid method for peak integration and integration tolerance of 20 p.p.m. Reporter ion intensities were adjusted to correct for the isotopic impurities of the different TMT reagents (manufacturer specifications).
Direct assessment of RNA cross-linking site in proteins. Starting from the methanol-precipitated OOPS interface, proteins were digested using 1 µ g Lys-C (Promega, Madison, WI, USA) in 100 µ L of 100 mM TEAB (Sigma-Aldrich) with 1 µ L of RNaseOUT (Thermo Fisher Scientific) overnight at 37 °C. Two different approaches were used to enriched RNA-peptides:
(i) Silica-based RNA purification using the RNeasy kit (Qiagen), according to the manufacturer's instructions; (ii) Precipitation in 80% ethanol. Two rounds of precipitations were used to further clean the sample.
RNA-peptides were resuspended in 100 µ L of 100 mM Tris-HCl (pH 8.0), 2 mM MgCl 2 , sonicated for 15 min and incubated at 95 °C for 20 min. Two micrograms RNase A/T1 mix (2 mg/mL of RNase A and 5,000 U/mL of RNase T1) was added to cooled samples and incubated for 4 h at 37 °C, followed by a second protease digestion using 1 µ g trypsin (Promega) overnight at 37 °C. Digested samples were desalted with Oligo R3 as described in "Proteomics sample preparation" and dried on a Speedvac (Labconco).
Digests were resuspended in 30-40 µ L of 80% acetonitrile (ACN)/2% TFA containing 1 µ g of TiO 2 beads (GL Sciences). The slurry was transferred to a p200 tip containing a C8 plug (3 M Empore, Sigma-Aldrich) to retain the loaded TiO 2 beads, and the flow-through was collected. The packed TiO 2 was washed with 20 µ L 80% ACN/2% TFA and then 20 µ L 10% ACN/0.1% TFA, and the flowthrough from both retained. The TiO 2 -enriched fraction was eluted from the beads with two rounds of 20 µ L of ammonia solution (1.5-1.8%), pH > 10.5, and 20 µ L of 50% ACN.
Proteomics bioinformatics and data analysis. Peptide-level output from Proteome Discoverer was reprocessed with the add_master_protein.py script (https://github.com/TomSmithCGAT/CamProt) to ensure uniform peptide-toprotein assignment for all samples from a single experiment and identify peptides that are likely to originate from contaminating proteins such as keratin (see Supplementary Note). For quantitative experiments, peptide-level quantification was obtained by summing the quantification values for all peptides with the same sequence but different modifications. Protein-level quantification was then obtained by taking the median peptide abundance. For SILAC experiments, the ratio between treatment and control protein abundance was calculated for each sample separately and aggregated to average protein ratio. For TMT experiments, data analysis was performed using the MSnbase R package 81 . Log 2 -transformed protein abundance was center-median normalized within each sample. For the crude fractionation experiments (n = 5), the protein abundance was quantified by label-free quantification, averaged across the replicates per fraction and normalized per protein such that the sum of abundances over the three fractions was 1. For the U2OS RBP-capture experiment, only proteins observed in all three CL replicates and no NC replicates were retained. In cross-link-testing SILAC experiments, only proteins present in at least two replicates were retained.
GO terms, Interpro protein domains and KEGG pathway annotations were obtained using the R package UniProt.ws 82 . GO terms were expanded to include all parent terms using the R package GO.db 83 . Glycoproteins were identified using the Uniprot 84 API with categories= PTM and types= CARBOHYD. Transmembrane proteins were identified using the Uniprot API with types= TRANSMEM.
Statistics. Data handling was performed with R v3.4.1 using tidyverse packages and python v3.6.5. Plotting was performed with the ggplot2 R package 85 . Proteins observed only in CL in at least one replicate were deemed enriched. For the RNase-testing SILAC experiments, proteins only ever observed in the RNase condition at the organic phase were deemed enriched. Conversely, those only ever observed in the control condition at the interfaces were deemed depleted. For proteins that did not meet these criteria, all peptides observed across the replicates were treated as independent observations and a two-tailed Mann-Whitney-Wilcoxon test was used to test whether the log 2 median CL/NC or RNase/Control ratio was > 0 (enriched) or < 0 (depleted), with a BH-adjusted P < 0.05 considered significant. Proteins with fewer than six peptides were excluded from the statistical test because of insufficient power.
GO, InterPro and KEGG over-representation analyses were conducted using the R package goseq. This package was originally developed to account for the relationship between the probability of a differentially expressed gene in RNAseq and the length of the gene by calculating a probability weight function to estimate the relationship between gene length and P(differential expression) and then approximating a null distribution for the number of genes expected to be differentially expressed from a given set (e.g., GO term) based on their length alone. An empirical P-value is then derived by comparing the number of observed genes to the null expectation. The package allows this approach to be generalized to any observation and any confounding factor. We used protein abundance because more abundant proteins are more likely to be detected and more likely to be detected as significantly altered in abundance due to relatively lower variance and thus increased statistical power. For U2OS and HEK293, protein abundance was derived from ref. 86 taking the maximum abundance recorded across the replicates. For MCF10A, we used an in-house deep proteomics dataset. For E. coli, protein abundance was obtained from PaxDB 87 . Proteins not present in the above reference datasets were excluded from the analysis. Resultant P-values were adjusted to account for multiple testing using the FDR procedure. GO terms and InterPro domains with adjusted P < 0.01 and at least five proteins were considered significantly over-represented. KEGG pathways with adjusted P < 0.05 and at least five proteins were considered significantly over-represented. Over-representation values given are not adjusted for protein abundance.
For the nocodazole arrest-and-release experiment, proteins with a change in abundance or RNA binding were identified using the lm function in R. Specifically, to identify protein with a change in abundance between nocodazole arrest and 6 h release, total protein abundance was modeled as a function of the time point alone (abundance ~ time point). The P-values for the time point coefficients for each proteins were adjusted to account for multiple hypothesis testing according to Benjamini and Hochberg 88 and proteins with an adjusted P < 0.01 (1% FDR) were considered to have changed abundance. To identify proteins with a change in RNA binding between nocodazole arrest and 6-h release, protein abundance in the total proteome and OOPS samples was modeled as a function of the time point, the abundance type (total or OOPS), and the interaction between these two variables (abundance ~ time point + type + (time point × type)). Here, the interaction term denotes whether the abundance in OOPS and total follows the same pattern across the time points (coefficient is zero), indicating total abundance determines the amount of protein bound to RNA, or diverges (nonzero coefficient), indicating a change in RNA binding between the time points. The P-values for the interaction term were obtained and adjusted as indicated above. For the heat map representation, protein abundances were z-score normalized within the total and OOPS samples separately. Hierarchical clustering was performed with the R hclust function using 1-Spearman's rho as the distance metric and average linkage.
For details of the identification of RNA binding sites, see Supplementary Note.
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Sample size
For the analysis of RNA species in the OOPS CL interface vs NC aqueous phase (figure 1), we used 4 replicates in each condition. The primary purpose of this experiment was to establish that the same RNAs were detected in each condition and 4 replicates was sufficient to determine this. For the assessment of the affect of crosslinking, OOPS wash stages and RNase treatments (figure 2), 4 replicates were obtained since these are SILAC experiments with low variability. For the identification of RBPs in U2OS using RBP capture (figure 3a), we used 3 replicates each of NC and CL and retained proteins seen in 3 CL and 0 NC samples. Previously published RBP capture experiments have used no replicates or just 2 replicates since this experiment requires considerable input material (e.g https://www.nature.com/articles/ ncomms12128). For the identification of RBPs in MCF10A ( figure 3b ) and E.coli (figure 6) using OOPS, we performed 5 replicate experiments and only retained proteins identified in all 5 replicates. This was sufficient since the protein IDs were very consistent between replicate experiments (see Figure 6a ). For the cell fractionation experiment (Figure 3f ), we obtained 5 replicates as we believed this would be sufficient to capture all RBPs present in each fraction. For the identification of RNA binding sites (figure 4), we obtained 3 replicates each of ethanolprecipitated and silica-retained RNA:peptide samples. We observed that this was sufficient to identify sites for 544 proteins (40% of all OOPS proteins). For the identification of changes in RNA binding upon release from nocodazole arrest (figure 5), we obtained 3 replicates at each timepoint. We chose 3 samples since a maximum of 10 samples could TMT labeled and quantified simultaneously. The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
Data exclusions
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation cells were fixed in 70% EtOH and DNA content was analysed using the Propidium Iodide Flow Cytometry Kit (Abcam, Cambridge, UK)
Instrument
Beckman Coulter CyAn ADP
